A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)

por Sahebjam, S, Bedard, P L, Castonguay, V, Chen, Z, Reedijk, M, Liu, G, Cohen, B, Zhang, W-J, Clarke, B, Zhang, T, Kamel-Reid, S, Chen, H, Ivy, S P, Razak, A R A, Oza, A M, Chen, E X, Hirte, H W, McGarrity, A, Wang, L, Siu, L L, Hotte, S J
Publicado 2013

VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide

por Orlandi, P, Fontana, A, Fioravanti, A, Di Desidero, T, Galli, L, Derosa, L, Canu, B, Marconcini, R, Biasco, E, Solini, A, Francia, G, Danesi, R, Falcone, A, Bocci, G
Publicado 2013

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder

por Xylinas, E, Kent, M, Kluth, L, Pycha, A, Comploj, E, Svatek, R S, Lotan, Y, Trinh, Q-D, Karakiewicz, P I, Holmang, S, Scherr, D S, Zerbib, M, Vickers, A J, Shariat, S F
Publicado 2013

Is community treatment best? a randomised trial comparing delivery of cancer treatment in the hospital, home and GP surgery

por Corrie, P G, Moody, A M, Armstrong, G, Nolasco, S, Lao-Sirieix, S-H, Bavister, L, Prevost, A T, Parker, R, Sabes-Figuera, R, McCrone, P, Balsdon, H, McKinnon, K, Hounsell, A, O'Sullivan, B, Barclay, S
Publicado 2013

Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy

por Marinovich, M L, Macaskill, P, Irwig, L, Sardanelli, F, von Minckwitz, G, Mamounas, E, Brennan, M, Ciatto, S, Houssami, N
Publicado 2013

Evaluating the role of fluorodeoxyglucose positron emission tomography-computed tomography in multi-disciplinary team recommendations for oesophago-gastric cancer

por Blencowe, N S, Whistance, R N, Strong, S, Hotton, E J, Ganesh, S, Roach, H, Callaway, M, Blazeby, J M
Publicado 2013

MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours

por Gits, C M M, van Kuijk, P F, Jonkers, M B E, Boersma, A W M, van IJcken, W F, Wozniak, A, Sciot, R, Rutkowski, P, Schöffski, P, Taguchi, T, Mathijssen, R H J, Verweij, J, Sleijfer, S, Debiec-Rychter, M, Wiemer, E A C
Publicado 2013

Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer

por Snoeren, N, Emmink, B L, Koerkamp, M J G, van Hooff, S R, Goos, J A C M, van Houdt, W J, de Wit, M, Prins, A M, Piersma, S R, Pham, T V, Belt, E J, Bril, H, Stockmann, H B, Meijer, G A, van Hillegersberg, R, Holstege, F C, Jimenez, C R, Fijneman, R J A, Kranenburg, O W, Rinkes, I H M Borel
Publicado 2013

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer

por Pfeiler, G, Königsberg, R, Hadji, P, Fitzal, F, Maroske, M, Dressel-Ban, G, Zellinger, J, Exner, R, Seifert, M, Singer, C, Gnant, M, Dubsky, P
Publicado 2013

Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?

por Broadbridge, V T, Karapetis, C S, Beeke, C, Woodman, R J, Padbury, R, Maddern, G, Kim, S W, Roder, D, Hakendorf, P, Price, T J
Publicado 2013

High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of no...

por Pichler, M, Hutterer, G C, Stojakovic, T, Mannweiler, S, Pummer, K, Zigeuner, R
Publicado 2013

Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy

por Langius, J A E, Bakker, S, Rietveld, D H F, Kruizenga, H M, Langendijk, J A, Weijs, P J M, Leemans, C R
Publicado 2013

The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study

por McCowan, C, Wang, S, Thompson, A M, Makubate, B, Petrie, D J
Publicado 2013

Low-dose aspirin use and cancer characteristics: a population-based cohort study

por Jonsson, F, Yin, L, Lundholm, C, Smedby, K E, Czene, K, Pawitan, Y
Publicado 2013

Association between serum 25(OH) vitamin D, incident liver cancer and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case–control study

por Wang, J-B, Abnet, C C, Chen, W, Dawsey, S M, Fan, J-H, Yin, L-Y, Yin, J, Major, J M, Taylor, P R, Qiao, Y-L, Freedman, N D
Publicado 2013

Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009–2010)

por Liniker, E, Harrison, M, Weaver, J M J, Agrawal, N, Chhabra, A, Kingshott, V, Bailey, S, Eisen, T G G, Corrie, P G
Publicado 2013

Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes

por Lauvrak, S U, Munthe, E, Kresse, S H, Stratford, E W, Namløs, H M, Meza-Zepeda, L A, Myklebost, O
Publicado 2013

The FGFR1 inhibitor PD173074 induces mesenchymal–epithelial transition through the transcription factor AP-1

por Nguyen, P T, Tsunematsu, T, Yanagisawa, S, Kudo, Y, Miyauchi, M, Kamata, N, Takata, T
Publicado 2013

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2

por Bedognetti, D, Spivey, T L, Zhao, Y, Uccellini, L, Tomei, S, Dudley, M E, Ascierto, M L, De Giorgi, V, Liu, Q, Delogu, L G, Sommariva, M, Sertoli, M R, Simon, R, Wang, E, Rosenberg, S A, Marincola, F M
Publicado 2013

Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis

por Celesti, G, Di Caro, G, Bianchi, P, Grizzi, F, Marchesi, F, Basso, G, Rahal, D, Delconte, G, Catalano, M, Cappello, P, Roncalli, M, Zerbi, A, Montorsi, M, Novelli, F, Mantovani, A, Allavena, P, Malesci, A, Laghi, L
Publicado 2013